Stay updated on Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:22:06.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on non-small cell lung cancer, while adding a new revision number and a study identifier.
    Difference
    46%
    Check dated 2025-04-16T10:37:32.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and removed a date reference of March 25, 2025, while adding a new date of December 27, 2024.
    Difference
    0.2%
    Check dated 2025-04-09T05:08:26.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new revision version (v2.14.3) and a new results posting date of March 25, 2025, replacing the previous estimated dates and version. This indicates a significant update in the content's accuracy and reliability.
    Difference
    0.3%
    Check dated 2025-04-01T22:12:01.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to include new details about the dosing and treatment protocols for a clinical study involving Nintedanib, Nivolumab, and Ipilimumab, while removing outdated information regarding previous study phases and results.
    Difference
    7%
    Check dated 2025-03-25T13:15:45.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-03-03T22:23:51.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.